Sarah Naomi Bolz - Concepedia

Concepedia

Author

Sarah Naomi Bolz

Technische Universität Dresden ORCID

Also Known As

Bolz, Sarah Naomi, Sarah Bolz, Sarah Naomi Bolz

18

Publications

2.2K

Citations

9

H-Index

33

Concepts

All Affiliations

Technische Universität Dresden Universität Hamburg

SN

About

Sarah Naomi Bolz is an author at Technische Universität Dresden specializing in medicine, drug discovery, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	179
2	Natural Sciences	2	2	162
3	Engineering	1	1	17
4	Biochemistry	1	1	60
5	Biostatistics	1	1	17

Sarah Naomi Bolz

×

9

Publications

2.2K

Citations

9

H-Index

	Year	Citations
PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA Melissa F. Adasme, Katja L Linnemann, Sarah Naomi Bolz, Nucleic Acids Research	2021	1.8K
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs Daniele Parisi, Melissa F. Adasme, Anastasia Sveshnikova, Computational and Structural Biotechnology Journal Drug TargetPharmacotherapyNew IndicationsDrug ClassTarget Repositioning	2020	102
PLIP 2025: introducing protein–protein interactions to the protein–ligand interaction profiler Philipp Schake, Sarah Naomi Bolz, Katja L Linnemann, Nucleic Acids Research	2025	81
Toward an Understanding of Pan-Assay Interference Compounds and Promiscuity: A Structural Perspective on Binding Modes Sarah Naomi Bolz, Melissa F. Adasme, Michael Schroeder Journal of Chemical Information and Modeling Protein AssemblyMolecular BiologyChemical BiologyMedicinal ChemistryPains Activity	2021	60
SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2 Lisa von Wenserski, Christoph Schultheiß, Sarah Naomi Bolz, Leukemia	2020	39
Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning Melissa F. Adasme, Sarah Naomi Bolz, Lauren Adelmann, International Journal of Molecular Sciences	2020	29
Deep Learning Improves Pancreatic Cancer Diagnosis Using RNA-Based Variants Ali Al-Fatlawi, Negin Malekian, Sebastián A. García, Cancers Systems BiologyFunctional GenomicsMachine LearningEngineeringPancreatic Cancer	2021	17
Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor Sarah Naomi Bolz, Sebastian Salentin, Gary Jennings, Computational and Structural Biotechnology Journal	2021	13
An improved high cell density cultivation—iHCDC—strategy for leucine auxotrophic <i>Escherichia coli</i> K12 ER2507 Björn Beckmann, Dorothea Hohmann, Moritz Eickmeyer, Engineering in Life Sciences	2017	10

Page 1